RELX stock slips early in London as buyback rolls on and Feb. 12 results loom
19 January 2026
1 min read

RELX stock slips early in London as buyback rolls on and Feb. 12 results loom

London, Jan 19, 2026, 08:05 GMT — Regular session

  • RELX shares dropped roughly 0.5% in early trading, underperforming the flat FTSE 100.
  • The most recent buyback the company reported accounted for 306,154 shares, now recorded as treasury stock.
  • Investors are bracing for full-year results due Feb. 12, watching closely for any updated guidance.

Shares of UK information and analytics firm RELX slipped 0.5% in early London trade on Monday, sliding to 3,077 pence following a weak start. 1

Investors are gearing up for the next key milestone: the full-year results. That’s when RELX usually lays out its growth outlook and cash return plans for the coming year. No major company updates surfaced over the weekend, so the stock is likely to follow the wider market’s lead.

The FTSE 100 barely moved at the open, with major U.S. stock indexes showing signs of weakness, tempering risk appetite as the week began. 2

RELX has been steadily buying back its own shares, providing a consistent floor for the stock during quieter market stretches. These buybacks shrink the number of shares outstanding, potentially boosting earnings per share even if overall profits remain unchanged.

RELX revealed in its latest filing that it purchased 306,154 ordinary shares on Jan. 16 via UBS AG London Branch. The price paid ranged from 3,071 pence to 3,120 pence per share. These shares will be held as treasury stock, meaning they remain on the company’s books instead of being cancelled. 3

Shares kicked off Monday at 3,075 pence, moving within a tight range initially. The action suggested caution, with no standout news driving the price.

RELX provides legal and scientific information, risk analytics, and exhibitions services—sectors that usually deliver recurring revenue but remain sensitive to customer budgets and renewal trends. Investors will focus closely on any shifts in growth momentum within the Legal and Risk divisions.

Buybacks can only go so far. If RELX’s update signals slower renewals, tougher pricing, or reduced demand for its U.S. tools, the stock may remain under pressure despite consistent repurchases.

RELX ended the day at 3,094 pence on Jan. 16, sitting comfortably above its 52-week low of 2,970 pence yet still quite a distance from its peak of 4,205 pence. 4

The upcoming trigger is the full-year earnings report on Feb. 12. Investors will zero in on the 2026 outlook and any updates on the pace of share buybacks. 5

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
Glencore share price rises as China scrutiny hangs over Rio Tinto merger talks
Previous Story

Glencore share price rises as China scrutiny hangs over Rio Tinto merger talks

Rio Tinto stock price edges up as Glencore deal filings land, China approval in spotlight
Next Story

Rio Tinto stock price edges up as Glencore deal filings land, China approval in spotlight

Go toTop